Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats

School of Studies in Chemistry and Biochemistry, Vikram University, Ujjain - 456 010, Madhya Pradesh, India.
Journal of pharmacy & bioallied sciences 04/2011; 3(2):242-8. DOI: 10.4103/0975-7406.80779
Source: PubMed

ABSTRACT To investigate the medicative effects of medium-polar (benzene:acetone, 1:1, v/v) extract of leaves from Stevia rebaudiana (family Asteraceae) on alloxan-induced diabetic rats.
Diabetes was induced in adult albino Wistar rats by intraperitoneal (i.p.) injection of alloxan (180 mg/kg). Medium-polar extract was administered orally at daily dose of 200 and 400 mg/kg body wt. basis for 10 days. The control group received normal saline (0.9%) for the same duration. Glibenclamide was used as positive control reference drug against Stevia extract.
Medium-polar leaf extract of S. rebaudiana (200 and 400 mg/kg) produced a delayed but significant (P < 0.01) decrease in the blood glucose level, without producing condition of hypoglycemia after treatment, together with lesser loss in the body weight as compared with standard positive control drug glibenclamide.
Treatment of diabetes with sulfonylurea drugs (glibenclamide) causes hypoglycemia followed by greater reduction in body weight, which are the most worrisome effects of these drugs. Stevia extract was found to antagonize the necrotic action of alloxan and thus had a re-vitalizing effect on β-cells of pancreas.

Download full-text


Available from: Himanshu Misra, Sep 29, 2015
62 Reads
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Stevia rebaudiana Bertoni is a plant used in the food industry as a sweetener but is also empirically used for the treatment of diabetes. The scientific literature has reported anticariogenic, antineoplastic, antihypertensive, anti-inflammatory and antihyperglycemic effects, among which the antihyperglycemic effect is the most reported. The aim of this study was to conduct a systematic review on those reported of the Stevia rebaudiana extract or components for potential diabetes treatments. Studies in vivo and in vitro indicate that the plant extract and a compound that is steviol-derived, stevioside, possess antihyperglycemic effect and their mechanisms of action is through suppression of gluconeogenesis (plant extract) and increased insulin secretion (plant extract and stevioside); rebaudioside A increases insulin secretion exclusively in vitro and with high concentrations of glucose.
    CyTA - Journal of Food 07/2014; 12(3). DOI:10.1080/19476337.2013.830150 · 0.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aspartame (APM) is an artificial sweetener used since the 1980s, now present in >6,000 products, including over 500 pharmaceuticals. Since its discovery in 1965, and its first approval by the US Food and Drugs Administration (FDA) in 1981, the safety of APM, and in particular its carcinogenicity potential, has been controversial. The present commentary reviews the adequacy of the design and conduct of carcinogenicity bioassays on rodents submitted by G.D. Searle, in the 1970s, to the FDA for market approval. We also review how experimental and epidemiological data on the carcinogenic risks of APM, that became available in 2005 motivated the European Commission (EC) to call the European Food and Safety Authority (EFSA) for urgent re-examination of the available scientific documentation (including the Searle studies). The EC has further requested that, if the results of the evaluation should suggest carcinogenicity, major changes must be made to the current APM specific regulations. Taken together, the studies performed by G.D. Searle in the 1970s and other chronic bioassays do not provide adequate scientific support for APM safety. In contrast, recent results of life-span carcinogenicity bioassays on rats and mice published in peer-reviewed journals, and a prospective epidemiological study, provide consistent evidence of APM's carcinogenic potential. On the basis of the evidence of the potential carcinogenic effects of APM herein reported, a re-evaluation of the current position of international regulatory agencies must be considered an urgent matter of public health. Am. J. Ind. Med. 9999;1-17, 2014 © 2014 Wiley Periodicals, Inc.
    American Journal of Industrial Medicine 04/2014; 57(4). DOI:10.1002/ajim.22296 · 1.74 Impact Factor
Show more